Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Equity Ratio (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Equity Ratio data on record, last reported at 0.39 in Q3 2025.

  • For Q3 2025, Equity Ratio fell 355.55% year-over-year to 0.39; the TTM value through Sep 2025 reached 0.39, down 355.55%, while the annual FY2024 figure was 0.09, 53.52% down from the prior year.
  • Equity Ratio reached 0.39 in Q3 2025 per GOSS's latest filing, down from 0.19 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.3 in Q3 2023 and bottomed at 0.39 in Q3 2025.
  • Average Equity Ratio over 4 years is 0.02, with a median of 0.09 recorded in 2024.
  • The widest YoY moves for Equity Ratio: up 353.98% in 2023, down 416.06% in 2023.
  • A 4-year view of Equity Ratio shows it stood at 0.04 in 2022, then soared by 353.98% to 0.2 in 2023, then plummeted by 53.52% to 0.09 in 2024, then crashed by 521.51% to 0.39 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.39 in Q3 2025, 0.19 in Q2 2025, and 0.02 in Q1 2025.